Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 CAD | +0.63% | +8.84% | -10.61% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
Sales 2024 * | 750K 548K | Sales 2025 * | 5.72M 4.18M | Capitalization | 121M 88.11M |
---|---|---|---|---|---|
Net income 2024 * | -35M -25.56M | Net income 2025 * | -40M -29.21M | EV / Sales 2024 * | 161 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 21.1 x |
P/E ratio 2024 * |
-3.65
x | P/E ratio 2025 * |
-3.71
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
1 day | +0.63% | ||
1 week | +8.84% | ||
Current month | +4.58% | ||
1 month | +2.56% | ||
3 months | +2.56% | ||
6 months | -31.91% | ||
Current year | -10.61% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.6 | +0.63% | 33,155 |
24-05-02 | 1.59 | +3.25% | 25,283 |
24-05-01 | 1.54 | +0.65% | 69,935 |
24-04-30 | 1.53 | +2.00% | 11,088 |
24-04-29 | 1.5 | +2.04% | 31,243 |
Delayed Quote Toronto S.E., May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.61% | 88.19M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ONC Stock